Inventor · disambiguated record
Roger Jeffs
Also filed as: JEFFS ROGER · JEFFS ROGER ANDREW
22 granted patents·7 pending applications·647 citations·filing 2004–2023
97Inventor score
Top patents by PatentIndex Score
29 records- 0198US9624156B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2015·Granted Apr 18, 2017·30 cites·31 claims
- 0298US9422223B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2015·Granted Aug 23, 2016·44 cites·16 claims
- 0398US9278901B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2015·Granted Mar 8, 2016·47 cites·12 claims
- 0497US9199908B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2014·Granted Dec 1, 2015·46 cites·11 claims
- 0596US11839631B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2020·Granted Dec 12, 2023·3 cites·10 claims
- 0696US11839596B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2021·Granted Dec 12, 2023·3 cites·7 claims
- 0796US11141393B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2018·Granted Oct 12, 2021·9 cites·10 claims
- 0896US10080730B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2014·Granted Sep 25, 2018·23 cites·11 claims
- 0996US7879909B2Use of Treprostinil to treat neuropathic diabetic foot ulcersUNITED THERAPEUTICS CORP·Filed 2005·Granted Feb 1, 2011·63 cites·21 claims
- 1095US7999007B2Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using sameUNITED THERAPEUTICS CORP·Filed 2008·Granted Aug 16, 2011·52 cites·26 claims
- 1194US8653137B2Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using sameUNITED THERAPEUTICS CORP·Filed 2013·Granted Feb 18, 2014·34 cites·13 claims
- 1294US8563614B2Use of treprostinil to treat neuropathic diabetic foot ulcersWADE MICHAEL·Filed 2010·Granted Oct 22, 2013·48 cites·9 claims
- 1394US7199157B2Use of treprostinil to improve kidney functionsUNITED THERAPEUTICS CORP·Filed 2004·Granted Apr 3, 2007·120 cites·13 claims
- 1493US10071123B2Treatment of pulmonary arterial hypertension with mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2013·Granted Sep 11, 2018·21 cites·3 claims
- 1593US10016463B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2013·Granted Jul 10, 2018·19 cites·16 claims
- 1692US10842823B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2018·Granted Nov 24, 2020·8 cites·20 claims
- 1792US8658694B2Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using sameJEFFS ROGER ANDREW·Filed 2011·Granted Feb 25, 2014·34 cites·26 claims
- 1889US12310992B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2023·Granted May 27, 2025·0 cites·12 claims
- 1988US8765813B2Use of treprostinil to treat and prevent ischemic lesionsWADE MICHAEL·Filed 2004·Granted Jul 1, 2014·42 cites·41 claims
- 2087US12274684B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2023·Granted Apr 15, 2025·0 cites·14 claims
- 2183US11666602B2Treatment of pulmonary arterial hypertension with mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2018·Granted Jun 6, 2023·1 cites·20 claims
- 2262US9327031B2Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using sameUNITED THERAPEUTICS CORP·Filed 2014·Granted May 3, 2016·0 cites·14 claims
- 2361US2008280986A1Treprostinil treatment for interstitial lung disease and asthmaUNITED THERAPEUTICS CORP·Filed 2008·Application pending·0 cites
- 2458US2014018431A1Treprostinil treatment for interstitial lung disease and asthmaUNITED THERAPEUTICS CORP·Filed 2013·Application pending·0 cites
- 2556US2013096200A1Treprostinil treatment for interstitial lung disease and asthmaUNITED THERAPEUTICS CORP·Filed 2012·Application pending·0 cites
- 2656US2008131398A1Combination therapy for treatment of viral infectionsUNITED THERAPEUTICS CORP·Filed 2007·Application pending·0 cites
- 2754US2012129941A1Treprostinil treatment for interstitial lung disease and asthmaWADE MICHAEL·Filed 2012·Application pending·0 cites
- 2853US2014288179A1Stable solutions of treprostinilUNITED THERAPEUTICS CORP·Filed 2014·Application pending·0 cites
- 2950US2013195798A1Combination therapy for treatment of viral infectionsUNITED THERAPEUTICS CORP·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →